VAI, initially developed by Amato et al. (14) in Western populations, has been found to be significantly associated with an increased risk of metabolic syndrome (MetS) components, cardiovascular and cerebrovascular events, making it a valuable indicator for assessing visceral obesity function and insulin sensitivity. Here, INS is linked to metabolic syndrome.